These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31836777)

  • 21. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.
    Lin Y; Zeng Q; Hu M; Peng G; Luo B;
    J Alzheimers Dis; 2021; 81(3):1285-1294. PubMed ID: 33935072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    van den Berg E; Geerlings MI; Biessels GJ; Nederkoorn PJ; Kloppenborg RP
    J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decline in executive function in patients with white matter hyperintensities from the static and dynamic perspectives of amplitude of low-frequency fluctuations.
    Cao S; Zhang J; Chen C; Wang X; Ji Y; Nie J; Tian Y; Qiu B; Wei Q; Wang K
    J Neurosci Res; 2021 Nov; 99(11):2793-2803. PubMed ID: 34510531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F; Morrison C; Maranzano J; Zeighami Y; Dadar M
    Geroscience; 2023 Feb; 45(1):1-16. PubMed ID: 36229760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
    Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R
    Neurology; 2021 Mar; 96(13):e1743-e1754. PubMed ID: 33597290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
    Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
    J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Early Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Healthy Elderly Samples Using Multimodal Neuroimaging Indices.
    Joshi H; Bharath S; Balachandar R; Sadanand S; Vishwakarma HV; Aiyappan S; Saini J; Kumar KJ; John JP; Varghese M
    Brain Connect; 2019 Nov; 9(9):730-741. PubMed ID: 31389245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    Kim H; Levine A; Cohen D; Gehrman P; Zhu X; Devanand DP; Lee S; Goldberg TE;
    J Alzheimers Dis; 2022; 87(4):1567-1580. PubMed ID: 35491776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic changes of amplitude of low-frequency in systemic lupus erythematosus patients with cognitive impairment.
    Yang Y; Zhao R; Zhang F; Bai R; Li S; Cui R; Liu S; Xu J
    Front Neurosci; 2022; 16():929383. PubMed ID: 36081656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
    Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
    Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    Ogama N; Sakurai T; Nakai T; Niida S; Saji N; Toba K; Umegaki H; Kuzuya M
    PLoS One; 2017; 12(3):e0172484. PubMed ID: 28253275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characteristic patterns of individual brain susceptibility networks underlie Alzheimer's disease and white matter hyperintensity-related cognitive impairment.
    Chen H; Xu J; Li W; Hu Z; Ke Z; Qin R; Xu Y
    Transl Psychiatry; 2024 Apr; 14(1):177. PubMed ID: 38575556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
    Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
    Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alzheimer's dementia, sleep disorders and nuclear medicine].
    Grammaticos P
    Hell J Nucl Med; 2005; 8(1):2-4. PubMed ID: 15886744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.